,NURS 6521 Week 2 Quiz | Advanced Pharmacology (2026)
Q&A | Walden University
1. Which of the following best describes the primary purpose of the Food and Drug
Administration's rigorous drug testing process?
A) To ensure that all drugs are affordable for consumers
B) To protect the public by ensuring the purity, safety, and efficacy of drugs
C) To guarantee that every drug will be effective for all patients
D) To limit the number of drugs available on the market
Correct Answer: To protect the public by ensuring the purity, safety, and efficacy of
drugs
Rationale: The primary purpose of the FDA's rigorous testing process is to protect
the public by ensuring that drugs are pure, safe, and effective for their intended use.
It does not guarantee effectiveness for every individual patient or address
affordability. The process is designed to evaluate risks and benefits before a drug is
approved for marketing.
2. What is the primary role of a nurse during phase III clinical trials of an
investigational drug?
A) Consulting on the choice of testing methodology
B) Administering the investigational drug to patients and monitoring for effects
C) Determining the final efficacy and safety of the drug
D) Recruiting healthy volunteers for the initial safety studies
,Correct Answer: Administering the investigational drug to patients and monitoring
for effects
Rationale: Nurses are generally most involved in phase III clinical trials, where they
may administer the investigational drug to patients and monitor for therapeutic and
adverse effects. The final determination of efficacy and safety is beyond the nurse's
scope, and consulting on testing methodology is not a routine nursing role.
Recruiting healthy volunteers is typically part of phase I trials.
3. According to the principles of pharmacogenomics, what primarily accounts for
unique individual responses to drugs?
A) The patient's age and weight
B) The patient's genetic makeup
C) The route of drug administration
D) The cost of the medication
Correct Answer: The patient's genetic makeup
Rationale: Pharmacogenomics is the study of how genetic variations influence
individual responses to drugs. It explores unique differences based on the mapping
of the human genome, allowing for personalized drug regimens. Age, weight, route
of administration, and cost are important factors but are not the primary focus of
pharmacogenomics.
4. A nurse practitioner is prescribing a medication to a patient of Chinese descent.
What pharmacokinetic factor should the nurse consider?
A) Chinese patients typically require higher doses of all medications
B) Chinese patients may have a greater number of lithium-activated receptors
, C) Chinese patients metabolize all drugs faster than other groups
D) Chinese patients are immune to most drug side effects
Correct Answer: Chinese patients may have a greater number of lithium-activated
receptors
Rationale: Research indicates that Chinese patients may have a greater number of
lithium-activated receptors, often requiring lower-than-normal doses of lithium. This
is an example of how genetic variations affect drug response. It is not accurate to
make broad generalizations about all medications or metabolism rates for any
population.
5. What is the primary purpose of a black box warning on a prescription medication?
A) To indicate the drug is available over the counter
B) To provide dosing instructions for pediatric patients
C) To highlight serious or life-threatening risks associated with the drug
D) To indicate the drug is contraindicated in all patients
Correct Answer: To highlight serious or life-threatening risks associated with the
drug
Rationale: A black box warning is the strongest safety warning required by the FDA,
highlighting serious or life-threatening adverse effects. It does not mean the drug is
contraindicated in all patients but requires careful consideration of risks and benefits.
It is not related to over-the-counter availability or pediatric dosing.
6. Which scheduled drug category includes drugs with no accepted medical use and
a high potential for abuse?
Q&A | Walden University
1. Which of the following best describes the primary purpose of the Food and Drug
Administration's rigorous drug testing process?
A) To ensure that all drugs are affordable for consumers
B) To protect the public by ensuring the purity, safety, and efficacy of drugs
C) To guarantee that every drug will be effective for all patients
D) To limit the number of drugs available on the market
Correct Answer: To protect the public by ensuring the purity, safety, and efficacy of
drugs
Rationale: The primary purpose of the FDA's rigorous testing process is to protect
the public by ensuring that drugs are pure, safe, and effective for their intended use.
It does not guarantee effectiveness for every individual patient or address
affordability. The process is designed to evaluate risks and benefits before a drug is
approved for marketing.
2. What is the primary role of a nurse during phase III clinical trials of an
investigational drug?
A) Consulting on the choice of testing methodology
B) Administering the investigational drug to patients and monitoring for effects
C) Determining the final efficacy and safety of the drug
D) Recruiting healthy volunteers for the initial safety studies
,Correct Answer: Administering the investigational drug to patients and monitoring
for effects
Rationale: Nurses are generally most involved in phase III clinical trials, where they
may administer the investigational drug to patients and monitor for therapeutic and
adverse effects. The final determination of efficacy and safety is beyond the nurse's
scope, and consulting on testing methodology is not a routine nursing role.
Recruiting healthy volunteers is typically part of phase I trials.
3. According to the principles of pharmacogenomics, what primarily accounts for
unique individual responses to drugs?
A) The patient's age and weight
B) The patient's genetic makeup
C) The route of drug administration
D) The cost of the medication
Correct Answer: The patient's genetic makeup
Rationale: Pharmacogenomics is the study of how genetic variations influence
individual responses to drugs. It explores unique differences based on the mapping
of the human genome, allowing for personalized drug regimens. Age, weight, route
of administration, and cost are important factors but are not the primary focus of
pharmacogenomics.
4. A nurse practitioner is prescribing a medication to a patient of Chinese descent.
What pharmacokinetic factor should the nurse consider?
A) Chinese patients typically require higher doses of all medications
B) Chinese patients may have a greater number of lithium-activated receptors
, C) Chinese patients metabolize all drugs faster than other groups
D) Chinese patients are immune to most drug side effects
Correct Answer: Chinese patients may have a greater number of lithium-activated
receptors
Rationale: Research indicates that Chinese patients may have a greater number of
lithium-activated receptors, often requiring lower-than-normal doses of lithium. This
is an example of how genetic variations affect drug response. It is not accurate to
make broad generalizations about all medications or metabolism rates for any
population.
5. What is the primary purpose of a black box warning on a prescription medication?
A) To indicate the drug is available over the counter
B) To provide dosing instructions for pediatric patients
C) To highlight serious or life-threatening risks associated with the drug
D) To indicate the drug is contraindicated in all patients
Correct Answer: To highlight serious or life-threatening risks associated with the
drug
Rationale: A black box warning is the strongest safety warning required by the FDA,
highlighting serious or life-threatening adverse effects. It does not mean the drug is
contraindicated in all patients but requires careful consideration of risks and benefits.
It is not related to over-the-counter availability or pediatric dosing.
6. Which scheduled drug category includes drugs with no accepted medical use and
a high potential for abuse?
